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Introduction: Large-scale sequencing studies often measure many related phenotypes in addition to the genetic
variants. Joint analysis of multiple phenotypes in genetic association studies may increase power to detect disease-
associated loci.
Methods: We apply a recently developed multivariate rare-variant association test to the Genetic Analysis Workshop
19 data in order to test associations between genetic variants and multiple blood pressure phenotypes simultaneously.
We also compare this multivariate test with a widely used univariate test that analyzes phenotypes separately.
Results: The multivariate test identified 2 genetic variants that have been previously reported as associated with
hypertension or coronary artery disease. In addition, our region-based analyses also show that the multivariate test
tends to give smaller p values than the univariate test.
Conclusions: Hence, the multivariate test has potential to improve test power, especially when multiple phenotypes
are correlated.Background
In many clinical or epidemiological studies, multiple
measures of related traits, that is, a multivariate pheno-
type, are collected. For example, in the Genetic Analysis
Workshop 19 (GAW19) data [1], both systolic and
diastolic blood pressures are available for each subject. It
is possible that these related traits share some common
genetic architecture either through pleiotropy—one
genetic variant influencing multiple traits [2, 3]—or by
contributions of different variants in the same gene [4].
Under such situations, multivariate methods may help in
genetic association studies, as they may add ability to
investigate the genetic architecture, and increase power
to detect disease-associated loci [5].* Correspondence: celia.greenwood@mcgill.ca
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(http://creativecommons.org/publicdomain/zeVarious methods for assessing associations between a
single genetic variant and multiple traits jointly have
been developed (summarized in Yang and Wang [6]).
However, individual variant tests can have limited power
to detect association with rare variants (with minor allele
frequency [MAF] less than 5 %). Consequently, region-
based tests have become a standard alternative approach
to summarize the genetic variability of a set of rare
variants in a defined region [7–9].
Recently, Sun et al. [10] proposed a novel region-based
multivariate test, MURAT (Multivariate Rare-variant
Association Test), for identifying rare-variant associa-
tions when multiple correlated continuous phenotypes are
observed. By assuming the variant effects to be randomly
distributed yet correlated, and allowing arbitrary correla-
tions among phenotypes, MURAT is more general than
the other comparable multivariate methods. In addition,
MURAT shows potential to improve test power especially
when there are pleiotropic effects or highly correlatedle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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GAW19 sequencing data for unrelated samples to identify
variants that are associated with blood pressure. In
addition, we also compare MURAT with the sequence
kernel association test (SKAT) [11], a widely used univari-
ate test for rare variant association.
Methods
Joint analysis of multiple phenotypes
Here we briefly summarize the MURAT method,
which is described in more detail in Sun et al. [10].
Suppose for each subject i, K correlated phenotypes,
Y i ¼ ðY i1;…;Y iK ÞT , are observed, and we are inter-
ested in detecting variants that are associated with
these phenotypes. For most region-based tests, a sin-
gle phenotype, Y ik , is linked with the genotype values
of a group of v SNPs, Gi ¼ ðGi1;…;GivÞT , and m covari-
ates, X i ¼ ðXi1;…;XimÞT , via a linear model Y ik ¼ α0k
þαTk X i þ βTk Gi þ εik for k ¼ 1;…;K, where α0k is a scalar
for intercept, αk ¼ ðαk1;…; αkmÞT and βk ¼ ðβk1;…; βkvÞT
are corresponding coefficient vectors, and εik is a random
error, assumed to follow a standard normal distribution.
For MURAT, however, K phenotypes are associated with
genotype and covariates jointly by using a multivariate





where α0 ¼ ðα01;…; α0K ÞT , α ¼ ðα11;…; α1m;…; αK1;…;
αKmÞT ¼ ðαT1 ;…;αTK ÞT , β ¼ ðβ11;…; β1v;…; βK1;…; βKvÞT
¼ ðβT1 ;…;βTK Þ
T
, εi ¼ ðεi1;…; εiK ÞT , IK is a K  K identity
matrix, and ⊗ represents Kronecker product. The variant
effect, β, in the above multivariate model is assumed to be
normally distributed, βeNKv 0;Σβ
 
. In addition, in order
to account for the correlations among Y ik ’s, the unknown
matrix Σβ is assumed to have a specific correlation
structure, such that there is correlation between βk and
βk′ for k≠k
′ . That is, there is a common correlation for
the effects of the same variant on different phenotypes,
Corr βkj; βk′j
 
¼ ρ for variant j, but the effects of differ-
ent variants are uncorrelated, so that Corr βkj; βk′j′
 
¼ 0
for variant j and variant j’. A score type statistic is derived
for MURAT to test whether β equals zero. With a data-
adaptive procedure to manage unknown correlations
among variant effects, βk , MURAT calculates the p values
analytically, and hence is fast enough to be used for a
genome-wide analysis.
Phenotypic and sequencing data
In this study, we focused on the 1943 unrelated Mexican
American samples provided by GAW19, and considered 2
phenotypes, systolic blood pressure (SBP) and diastolic
blood pressure (DBP). Age and sex were used as covariates.After removing subjects who have one or both missing
phenotypes, a total of 1851 individuals were considered in
the analysis. We applied a log transformation to SBP and
DBP so as to eliminate skewness; the correlation between
log SBP and log DBP was 0.542.
Single-variant tests
Although MURAT and SKAT were designed for region-
based rare-variant association studies, they can also be
used for single-variant tests. Hence, we selected all
exomic variants of the odd-numbered chromosomes
provided by GAW19. However, because a lot of these
variants are very rare, possibly observed only once or
twice, we restricted analysis to only the variants that had
4 or more carriers. As a consequence, a total of 152,337
single-nucleotide polymorphisms (SNPs) were included.
Missing genotype values were imputed by the corre-
sponding variant MAFs so that the MAFs didn’t change
after imputation.
Region-based tests
To explore the performance of MURAT as a region-
based test, we also applied it to various predefined
variant sets. We first used the hg19 reference as the an-
notation file (see https://www.cog-genomics.org/static/
bin/plink/glist-hg19) to obtain gene start and gene end
positions to define gene-based regions, and then imple-
mented MURAT and SKAT for each gene. In total,
10,886 genes that contain variants in the unrelated
GAW19 genotype data were included in the analysis.
We also analyzed the GAW19 data using a series of
non-overlapping windows of 30 kb, spanning all pro-
vided SNPs, which yielded 13,094 windows, and applied
MURAT and SKAT to these mutually exclusive regions.
Moreover, we performed a focused comparison of MU-
RAT with SKAT for 15 genes that have been reported as
associated with hypertension at p < 1.0 10−5 according
to the National Institutes of Health (NIH) Genome-
Wide Association Studies (GWAS) catalog [12].
Results
For single-variant tests, to adjust for multiple testing, a
Bonferroni-corrected threshold, p<0.05/152,337=3.28 
10−7 would be needed. There were 4 SNPs where MUR-
AT’s p value met this level of significance. However, this
threshold is likely to be conservative as it assumes inde-
pendence of all tests. Therefore, Table 1 lists all SNPs
with p values less than 10−6 obtained by either SKAT or
MURAT. The MURAT p values are smaller than either
of the two SKAT p values at 7 of the 8 SNPs in Table 1.
The region-based p values obtained from applying
MURAT and SKAT to 10,866 genes are plotted in Fig. 1;
for SKAT, twice the minimum of the SBP and DBP-
based p values are shown. Figure 1 clearly shows that
Table 1 Results of single-variant association tests for all SNPs where either MURAT or SKAT (of either phenotype) showed evidence
of association at p<10−6
p Values
SKAT MURAT
chr rsID Nearest gene MAF SBP DBP BOTH
1 rs4926600 CYP4A22 0.0825 3.05e-03 1.39e-01 1.10e-07
1 var_1_91818773 0.0011 3.83e-01 8.23e-04 8.51e-07
3 rs79314450 HRH1 0.0014 4.95e-02 4.21e-03 1.75e-08
7 rs116690173 INMT 0.0016 3.12e-01 2.47e-03 6.23e-07
7 rs79584800 FAM188B 0.0014 2.91e-01 8.14e-04 2.61e-07
17 var_17_61987931 0.0011 9.34e-07 6.08e-04 6.26e-06
19 rs138635091 FBN3 0.0016 1.94e-01 6.33e-04 3.11e-08
19 rs115045946 APOC4 0.0022 1.09e-01 1.51e-02 5.10e-07
MAF minor allele frequency
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SKAT p values. In addition, in Fig. 2 we also show the
corresponding quantile–quantile (Q-Q) plots for MU-
RAT and SKAT, respectively. Because the Q-Q plots
show that p values obtained from both MURAT and
SKAT follow the expected distribution under the null, we
can draw the conclusion from Fig. 1 that MURAT has po-
tential to improve test power over single-phenotype tests.
A Bonferroni threshold here would require p<4.6  10−6
but no genes met this threshold. Using a more liberal
threshold of p<10−4, Table 2 displays all genes where evi-
dence of association was identified with either SKAT or
MURAT. In our analysis of 13,094 non-overlapping
windows of 30 kb, no regions showed significance at aFig. 1 Comparison of −log10 p values between MURAT and
univariate tests for region-based analysis of each of 10,866 genes.
For the single-phenotype tests, a Bonferroni correction was applied
to the minimum of the 2 p valuesBonferroni-corrected level of 3.8  10−6, or a more liberal
threshold of p<10−5.
Figure 3 compares the gene-based multivariate MURAT
with single-phenotype analyses for 15 genes where associ-
ation with hypertension has been well demonstrated in
the NIH-GWAS catalog. Although none of these genes
show strong evidence of statistical significance in these
data, some stronger single-SNP–single-phenotype associa-
tions are decreased when using MURAT. However, most
of the points in Fig. 3 fall above the diagonal line, suggest-
ing a possible power benefit after adjustment for multiple
testing. Hence, it may be a beneficial strategy to incorpor-
ate a multivariate test into the analysis plan when design-
ing or planning a study.Fig. 2 Quantile–quantile (Q-Q) plot for p values obtained by using
MURAT and adjusted p values obtained by using SKAT to test 10,866
genes. The adjusted p values are defined as twice the minimum of
the SBP and DBP-based p values obtained via SKAT
Table 2 Results of region-based analysis of all genes where
either MURAT or SKAT (of either phenotype) showed evidence
of association at p<10−4
p Values
SKAT MURAT
chr Gene # of SNPs SBP DBP BOTH
1 HIST3H2BB 4 5.42e-04 1.07e-02 6.43e-05
3 MIR425 1 2.95e-02 1.70e-01 2.92e-05
3 TPRG1-AS2 3 2.62e-01 5.55e-05 6.79e-04
9 ZBTB43 21 4.85e-02 9.20e-05 2.61e-03
15 ZNF280D 63 1.03e-02 8.94e-05 1.07e-03
17 SAT2 17 4.31e-03 5.52e-05 8.29e-04
17 SHBG 58 5.54e-03 3.40e-05 5.85e-04
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In this study, we investigated the performance of a joint
analysis of multiple phenotypes for genetic association
studies by applying MURAT, a novel region-based multi-
variate test for rare variants, to the GAW19 unrelated
samples. The results show that when multiple pheno-
types are correlated, the multivariate test can be more
powerful than the univariate test.
For the most significant SNPs listed in Table 1, MU-
RAT often estimated significance levels substantially
smaller than the single-phenotype analyses; hence it may
be more powerful than SKAT. For the one notable ex-
ception to this pattern in Table 1 (var_17_61987931 onFig. 3 Comparison of p values testing for association between the gene-
based MURAT test, and single-phenotype tests with either gene-based or
single-SNP–based analyses, for 15 known hypertension-associated genes
selected from the NIH-GWAS catalog, and occurring on odd-numbered
chromosomes. For the single phenotype tests, Bonferroni corrections
were applied to adjust the p values for testing 2 traits and, for single-
variant test results, also for testing all SNPs in a genechromosome 17), there was strong association only with
SBP. If a variant is only associated with one of the phe-
notypes, a joint analysis with the other traits will add
noise to the multivariate test.
Some of the SNPs in Table 1 are in or near genes that
are good candidates for hypertension. In particular, SNP
rs4926600 on chromosome 1 is within gene CYP4A22,
which was previously reported to be associated with es-
sential hypertension [13, 14]. Similarly, SNP rs115045946
on chromosome 19 is near to gene APOC4, which is asso-
ciated with coronary artery disease [15]. Comparing gene-
based tests (see Table 2) with single SNP tests (see Table 1),
we found that the region based tests in this study did not
seem to demonstrate improved power over the single vari-
ant tests. This has also been found by others [16, 17], and
is likely because the region based tests are sensitive to the
proportion of causal variants in a region and lose power
when many neutral variants are included.
Hence, power for region-based tests should be best
when there are many causal variants. To investigate power
of this multivariate test in a situation where associations
are likely to be real, we focused on 15 known hypertension
associated genes (occurring on odd-numbered chromo-
somes). Figure 2 suggests that there may be benefit to
multivariate region-based tests, if adjustments for multiple
testing are applied, and if there is some association with
all of the phenotypes.
We have shown [10] that compared with the univariate
tests, the MURAT approach is more powerful, especially
when there exist pleiotropic effects or highly correlated
traits, but it is also subject to possible power loss when
many neutral variants exist, or when variants are only asso-
ciated with a subset of all traits. Hence, for joint analysis of
multiple phenotypes, valuable future work should include
developing reliable methods to select the best genetic re-
gions for analysis, and the possibility of combining the uni-
variate and the multivariate test together in an optimal
manner, in order to ensure the best power under various
genetic architectures.
Conclusions
The new multivariate rare variant test MURAT demon-
strated interesting results in joint analysis of systolic and
diastolic blood pressure phenotypes in GAW19 unre-
lated individuals, and identified some loci that are plaus-
ible candidates for association with hypertension.
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